Pharmacy chain Walgreens Boots Alliance (NASDAQ: WBA) and its market-topping 4.1% dividend yield can help investors crush inflation. Lastly, pharmaceuticals are responsible for the bulk of J&J's margins and growth in the near term, although brand-name drugs have a finite period of sales exclusivity. Whereas most co-located clinics can only handle so much as a sniffle, this full-service partnership, complete with onsite physicians, could draw repeat patients, improve brand loyalty, and drive business to Walgreens' higher-margin pharmacy segment.